Literature DB >> 8086328

Modifications in peripheral hemodynamics and left ventricular function in hypertensives treated with nicardipine slow release.

E Arosio, P Pancera, I Seiban, F Priante, M Ribul, S De Marchi, G Montresor, A Lechi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8086328     DOI： 10.1007/bf00877106

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN： 0920-3206            Impact factor:   3.727


× No keyword cloud information.
  9 in total

Review 1.  Hypertension and left ventricular diastolic function.

Authors:  R F Shepherd; P K Zachariah; C Shub
Journal:  Mayo Clin Proc       Date:  1989-12       Impact factor: 7.616

2.  Is reversal of cardiac hypertrophy a desirable goal of antihypertensive therapy?

Authors:  R C Tarazi; E D Frohlich
Journal:  Circulation       Date:  1987-01       Impact factor: 29.690

3.  Role of blood pressure in the development of congestive heart failure. The Framingham study.

Authors:  W B Kannel; W P Castelli; P M McNamara; P A McKee; M Feinleib
Journal:  N Engl J Med       Date:  1972-10-19       Impact factor: 91.245

Review 4.  Vascular changes in hypertension. Therapeutic implications.

Authors:  B Folkow
Journal:  Drugs       Date:  1985       Impact factor: 9.546

5.  Clinical evaluation of Dinamap 845 automated blood pressure recorder.

Authors:  J H Silas; A T Barker; L E Ramsay
Journal:  Br Heart J       Date:  1980-02

Review 6.  Clinical studies of drug reversal of hypertensive left ventricular hypertrophy.

Authors:  P R Liebson
Journal:  Am J Hypertens       Date:  1990-06       Impact factor: 2.689

7.  Nicardipine hydrochloride in essential hypertension--a controlled study.

Authors:  J Asplund
Journal:  Br J Clin Pharmacol       Date:  1985       Impact factor: 4.335

8.  Antihypertensive effect of slow-release nicardipine. A placebo-controlled cross-over study.

Authors:  A Salvetti; G Cardellino; M Pesenti; A Caiazza; F Ghisoni; C Del Prato; P F Innocenti; F Ponzanelli; M Errico; M Freda
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

9.  Regression of cardiac hypertrophy after antihypertensive therapy with nifedipine and captopril.

Authors:  I Sheiban; G Arcaro; G Covi; R Accardi; C Zenorini; A Lechi
Journal:  J Cardiovasc Pharmacol       Date:  1987       Impact factor: 3.105
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.